Robert J Hugin's Net Worth
$286 Million
Who is Robert J Hugin?
Robert J Hugin has an estimated net worth of $286 Million. This is based on reported shares across multiple companies, which include DANAHER CORP /DE/, Chubb Ltd, Coley Pharmaceutical Group, Inc., Biohaven Pharmaceutical Holding Co Ltd., Allergan plc, CELGENE CORP /DE/, Biohaven Ltd., and MEDICINES CO /DE.
SEC CIK
Robert J Hugin's CIK is 0001232505
Past Insider Trading and Trends
2005 was Robert J Hugin's most active year for acquiring shares with 43 total transactions. Robert J Hugin's most active month to acquire stocks was the month of April. 2005 was Robert J Hugin's most active year for disposing of shares, totalling 37 transactions. Robert J Hugin's most active month to dispose stocks was the month of August. 2013 saw Robert J Hugin paying a total of $12,108,074.58 for 684,321 shares, this is the most they've acquired in one year. In 2014 Robert J Hugin cashed out on 1,684,101 shares for a total of $83,265,175.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DANAHER CORP /DE/ (DHR) Snapshot price: $247.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.28% | 990 |
—
|
—
| 3.58K |
May 15
| |||
Form 4/A
| +60.02% | 970 |
—
|
—
| 2.59K |
Jul 15
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 970 |
—
|
—
| 970 |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Chubb Ltd (CB) Snapshot price: $246.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.00% | 1.63K |
—
|
—
| 17.98K |
May 17
| |||
Form 4
| +10.81% | 1.59K |
—
|
—
| 16.35K |
May 19
| |||
Form 4
| +14.21% | 1.84K |
—
|
—
| 14.75K |
May 20
| |||
Form 4
| +29.16% | 2.92K |
—
|
—
| 12.92K |
May 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Coley Pharmaceutical Group, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Biohaven Pharmaceutical Holding Co Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.90K |
$148.50 | -$430,650.00 |
0
|
Oct 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allergan plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.29K |
—
|
—
|
0
|
May 8
| |||
Form 4
| -32.46% | -2.06K |
$189.74 | -$391,623.36 | 4.29K |
May 1
| |||
Form 4
| +54.26% | 1.86K |
$146.17 | $269,826.12 | 5.29K |
Apr 30 - May 2
| |||
Form 4
| +14.20% | 426 |
$139.07 | $59,243.82 | 3.43K |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||